Back

Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir

Dai, E. Y.; Lee, K. A.; Nathanson, A. B.; Leonelli, A. T.; Petros, B. A.; Brock-Fisher, T.; Dobbins, S. T.; MacInnis, B. L.; Capone, A.; Littlehale, N.; Boucau, J.; Marino, C.; Barczak, A. K.; Sabeti, P. C.; Springer, M.; Stephenson, K. E.

2022-08-04 infectious diseases
10.1101/2022.08.04.22278378 medRxiv
Show abstract

We measured viral kinetics of SARS-CoV-2 Omicron infection in 36 mRNA-vaccinated individuals, 11 of whom were treated with nirmatrelvir-ritonavir (NMV-r). We found that NMV-r was associated with greater incidence of viral rebound compared to no treatment. For those that did not rebound, NMV-r significantly reduced time to PCR conversion.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.